Literature DB >> 3678747

Localization of specific binding sites for bombesin in the canine gastrointestinal tract.

S R Vigna1, C R Mantyh, A S Giraud, A H Soll, J H Walsh, P W Mantyh.   

Abstract

The goal of these studies was to determine the tissue and cell types possessing specific binding sites for bombesin/gastrin-releasing peptide in the canine gastrointestinal tract. Monoiodinated, biologically active (Tyr-4)-bombesin 14 (100 pM) was applied to sections of canine gut and localized using quantitative autoradiography. The highest density of bombesin/gastrin-releasing peptide specific binding sites occurred over endocrine cells in the antral mucosa. Specific binding sites were also found on the circular muscle layer of the gastric fundus, gastric antrum, and ileum, on longitudinal muscle of the gastric fundus and antrum, and on neuronal elements in the myenteric plexus in the gastric fundus, antrum, and small intestine. No evidence for specific binding of 125I-(Tyr-4)-bombesin 14 was found in sections of canine esophagus, gastric cardia, gallbladder, pancreas, or colon. These results suggest sites of direct action of bombesin and endogenous gastrin-releasing peptide for gastrin release and gastrointestinal motility.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678747     DOI: 10.1016/0016-5085(87)90257-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast.

Authors:  M Gugger; J C Reubi
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 2.  Insights into bombesin receptors and ligands: Highlighting recent advances.

Authors:  Irene Ramos-Álvarez; Paola Moreno; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Terry W Moody; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-05-11       Impact factor: 3.750

3.  Vasoactive intestinal peptide. An inhibitor of feline gastric smooth muscle in vitro.

Authors:  A Merlo; S Cohen
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

4.  Distribution of vasoactive intestinal polypeptide and substance P receptors in human colon and small intestine.

Authors:  L Y Korman; H Sayadi; B Bass; T W Moody; J W Harmon
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

5.  Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.

Authors:  Beatrice Waser; Véronique Eltschinger; Karen Linder; Adrian Nunn; Jean Claude Reubi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-15       Impact factor: 9.236

6.  Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours.

Authors:  Rosalba Mansi; Xuejuan Wang; Flavio Forrer; Beatrice Waser; Renzo Cescato; Keith Graham; Sandra Borkowski; Jean Claude Reubi; Helmut R Maecke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-18       Impact factor: 9.236

7.  Alteration in gastric nerve fibers containing gastrin-releasing peptide in relation to the gastrin-producing cell population after truncal vagotomy in a rat model.

Authors:  H Shimoda; Y Uchida; S Murakami; T Noguchi; S Yokoyama; I Nakayama; M Takeyama
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  High-affinity binding sites for bombesin on mouse colonic mucosal membranes.

Authors:  S Narayan; E Draviam; S Rajaraman; P Singh
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

9.  A rhesus monkey model to characterize the role of gastrin-releasing peptide (GRP) in lung development. Evidence for stimulation of airway growth.

Authors:  K Li; S R Nagalla; E R Spindel
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

10.  Role of bombesin on gut mucosal growth.

Authors:  K U Chu; B M Evers; J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.